- Home
- FMX vs DXCM Comparison
FMX vs DXCM Comparison
Compare FMX & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMX
- DXCM
- Stock Information
- Founded
- FMX 1890
- DXCM 1999
- Country
- FMX Mexico
- DXCM United States
- Employees
- FMX N/A
- DXCM N/A
- Industry
- FMX Beverages (Production/Distribution)
- DXCM Medical/Dental Instruments
- Sector
- FMX Consumer Staples
- DXCM Health Care
- Exchange
- FMX Nasdaq
- DXCM Nasdaq
- Market Cap
- FMX 34.6B
- DXCM 28.0B
- IPO Year
- FMX 1998
- DXCM 2005
- Fundamental
- Price
- FMX $90.09
- DXCM $75.88
- Analyst Decision
- FMX Buy
- DXCM Buy
- Analyst Count
- FMX 5
- DXCM 17
- Target Price
- FMX $120.33
- DXCM $101.29
- AVG Volume (30 Days)
- FMX 665.1K
- DXCM 5.0M
- Earning Date
- FMX 10-28-2024
- DXCM 10-24-2024
- Dividend Yield
- FMX 0.17%
- DXCM N/A
- EPS Growth
- FMX N/A
- DXCM 83.21
- EPS
- FMX 0.33
- DXCM 1.67
- Revenue
- FMX $38,592,565,124.00
- DXCM $3,954,000,000.00
- Revenue This Year
- FMX $14.65
- DXCM $13.10
- Revenue Next Year
- FMX $9.50
- DXCM $14.82
- P/E Ratio
- FMX $25.40
- DXCM $45.51
- Revenue Growth
- FMX 13.58
- DXCM 16.19
- 52 Week Low
- FMX $90.01
- DXCM $62.34
- 52 Week High
- FMX $143.43
- DXCM $142.00
- Technical
- Relative Strength Index (RSI)
- FMX 24.57
- DXCM 64.11
- Support Level
- FMX $93.32
- DXCM $71.75
- Resistance Level
- FMX $97.92
- DXCM $75.47
- Average True Range (ATR)
- FMX 2.08
- DXCM 2.37
- MACD
- FMX -0.55
- DXCM 0.52
- Stochastic Oscillator
- FMX 0.82
- DXCM 78.60
About FMX Fomento Economico Mexicano S.A.B. de C.V.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and around 90% of profits in 2023.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.